These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 37710394)

  • 1. Mental Health Staff's Perspectives on Tapering of Antipsychotic Medication: A Focus Group Study.
    Roed K; Buus N; Nielsen J; Christensen PS; Midtgaard J
    Qual Health Res; 2023 Nov; 33(13):1165-1176. PubMed ID: 37710394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical experiences of guided tapering of antipsychotics for patients with schizophrenia- a case series.
    Mølgaard SN; Nielsen MØ; Roed K; Nielsen J
    BMC Psychiatry; 2024 Mar; 24(1):240. PubMed ID: 38553687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TAILOR - tapered discontinuation versus maintenance therapy of antipsychotic medication in patients with newly diagnosed schizophrenia or persistent delusional disorder in remission of psychotic symptoms: study protocol for a randomized clinical trial.
    Stürup AE; Jensen HD; Dolmer S; Birk M; Albert N; Nielsen M; Hjorthøj C; Eplov L; Ebdrup BH; Mors O; Nordentoft M
    Trials; 2017 Sep; 18(1):445. PubMed ID: 28962668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Switching antipsychotic medication to reduce sexual dysfunction in people with psychosis: the REMEDY RCT.
    Crawford MJ; Thana L; Evans R; Carne A; O'Connell L; Claringbold A; Saravanamuthu A; Case R; Munjiza J; Jayacodi S; Reilly JG; Hughes E; Hoare Z; Barrett B; Leeson VC; Paton C; Keown P; Pappa S; Green C; Barnes TR
    Health Technol Assess; 2020 Sep; 24(44):1-54. PubMed ID: 32930090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. De-escalation of conflict in forensic mental health inpatient settings: a Theoretical Domains Framework-informed qualitative investigation of staff and patient perspectives.
    Johnston I; Price O; McPherson P; Armitage CJ; Brooks H; Bee P; Lovell K; Brooks CP
    BMC Psychol; 2022 Feb; 10(1):30. PubMed ID: 35168682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk and protective factors for relapse among individuals with schizophrenia: a qualitative study in Dar es Salaam, Tanzania.
    Sariah AE; Outwater AH; Malima KI
    BMC Psychiatry; 2014 Aug; 14():240. PubMed ID: 25168715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perspectives on reasons for non-adherence to medication in persons with schizophrenia in Ethiopia: a qualitative study of patients, caregivers and health workers.
    Teferra S; Hanlon C; Beyero T; Jacobsson L; Shibre T
    BMC Psychiatry; 2013 Jun; 13():168. PubMed ID: 23773362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
    Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
    Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of a thematic analysis to explore the experiences of patients with schizophrenia taking antipsychotic medication.
    Rofail D; Heelis R; Gournay K
    Clin Ther; 2009 Jun; 31 Pt 1():1488-96. PubMed ID: 19698906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antipsychotic switching for people with schizophrenia who have neuroleptic-induced weight or metabolic problems.
    Mukundan A; Faulkner G; Cohn T; Remington G
    Cochrane Database Syst Rev; 2010 Dec; (12):CD006629. PubMed ID: 21154372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of a Web-Based Shared Decision-Making Program: Impact on Ongoing Treatment Engagement and Antipsychotic Adherence.
    Finnerty MT; Layman DM; Chen Q; Leckman-Westin E; Bermeo N; Ng-Mak DS; Rajagopalan K; Hoagwood KE
    Psychiatr Serv; 2018 Dec; 69(12):1215-1221. PubMed ID: 30286709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of trust and hope in antipsychotic medication reviews between GPs and service users a realist review.
    Grünwald LM; Duddy C; Byng R; Crellin N; Moncrieff J
    BMC Psychiatry; 2021 Aug; 21(1):390. PubMed ID: 34348680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].
    Llorca PM; Miadi-Fargier H; Lançon C; Jasso Mosqueda G; Casadebaig F; Philippe A; Guillon P; Mehnert A; Omnès LF; Chicoye A; Durand-Zaleski I
    Encephale; 2005; 31(2):235-46. PubMed ID: 15959450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of patients' and staff's perspectives on the causes of violence and aggression in psychiatric inpatient settings: An integrative review.
    Fletcher A; Crowe M; Manuel J; Foulds J
    J Psychiatr Ment Health Nurs; 2021 Oct; 28(5):924-939. PubMed ID: 33837640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risperidone (depot) for schizophrenia.
    Sampson S; Hosalli P; Furtado VA; Davis JM
    Cochrane Database Syst Rev; 2016 Apr; 4(4):CD004161. PubMed ID: 27078222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intermittent drug techniques for schizophrenia.
    Sampson S; Mansour M; Maayan N; Soares-Weiser K; Adams CE
    Cochrane Database Syst Rev; 2013 Jul; (7):CD006196. PubMed ID: 23881657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The needs of patients receiving depot antipsychotic medication within primary care.
    Phelan M; Mirza I
    Fam Pract; 2003 Apr; 20(2):126-8. PubMed ID: 12651784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuing, reducing, switching, or stopping antipsychotics in individuals with schizophrenia-spectrum disorders who are clinically stable: a systematic review and network meta-analysis.
    Ostuzzi G; Vita G; Bertolini F; Tedeschi F; De Luca B; Gastaldon C; Nosé M; Papola D; Purgato M; Del Giovane C; Correll CU; Barbui C
    Lancet Psychiatry; 2022 Aug; 9(8):614-624. PubMed ID: 35753323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A peer support programme for enhancing adherence to oral antipsychotic medication in consumers with schizophrenia.
    Boardman G; McCann T; Kerr D
    J Adv Nurs; 2014 Oct; 70(10):2293-302. PubMed ID: 24628395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment.
    Lewis SW; Davies L; Jones PB; Barnes TR; Murray RM; Kerwin R; Taylor D; Hayhurst KP; Markwick A; Lloyd H; Dunn G
    Health Technol Assess; 2006 May; 10(17):iii-iv, ix-xi, 1-165. PubMed ID: 16707074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.